Anzalone Christopher Richard
Insider CIK 1423029 · ARWR President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-01-02 | 2026-01-05 | 7,416 | $65.88 | $488.6K | 3,798,510 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-01-02 | 2026-01-05 | 5,771 | $66.39 | $383.1K | 3,792,739 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 35,181 | — | $0 | 16,545 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 16,545 | — | $0 | 0 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 35,181 | $6.15 | $216.4K | 3,841,107 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 16,545 | $6.15 | $101.8K | 3,857,652 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-29 | 2025-12-30 | 35,181 | $69.33 | $2.44M | 3,822,471 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-29 | 2025-12-30 | 16,545 | $68.69 | $1.14M | 3,805,926 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-22 | 2025-12-23 | 10,012 | $68.33 | $684.1K | 3,808,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-22 | 2025-12-23 | 2,574 | $68.85 | $177.2K | 3,805,926 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 1,319 | $68.48 | $90.3K | 3,818,512 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 8,147 | $68.01 | $554.1K | 3,819,831 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 3,979 | $66.67 | $265.3K | 3,827,978 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-17 | 2025-12-19 | 46,287 | $63.55 | $2.94M | 3,870,670 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-17 | 2025-12-19 | 1,981 | $66.30 | $131.3K | 3,831,957 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-17 | 2025-12-19 | 982 | $65.53 | $64.4K | 3,833,938 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-17 | 2025-12-19 | 35,750 | $64.51 | $2.31M | 3,834,920 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 6,661 | $64.29 | $428.2K | 3,922,644 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 8,416 | $60.51 | $509.3K | 3,962,839 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 10,963 | $61.25 | $671.5K | 3,951,876 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 14,095 | $62.12 | $875.6K | 3,937,781 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 8,476 | $62.94 | $533.5K | 3,929,305 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 1,000 | $64.96 | $65.0K | 3,921,644 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 1,300 | $65.77 | $85.5K | 3,920,344 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 166 | $66.77 | $11.1K | 3,920,178 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-16 | 2025-12-16 | 3,221 | $67.87 | $218.6K | 3,916,957 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-15 | 2025-12-16 | 100,532 | $68.67 | $6.90M | 4,000,723 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-15 | 2025-12-16 | 21,321 | $69.28 | $1.48M | 3,979,402 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-15 | 2025-12-16 | 8,147 | $69.96 | $570.0K | 3,971,255 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-12 | 2025-12-16 | 180,000 | — | $0 | 4,101,255 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-04-11 | 2025-04-11 | 50,800 | $11.49 | $583.7K | 3,921,255 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-04-10 | 2025-04-11 | 50,000 | $10.87 | $543.5K | 3,972,055 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-04-09 | 2025-04-11 | 35,305 | $9.93 | $350.6K | 4,027,072 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-04-09 | 2025-04-11 | 3,400 | $10.75 | $36.5K | 4,023,672 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-04-09 | 2025-04-11 | 1,617 | $11.76 | $19.0K | 4,022,055 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-03-13 | 2025-03-17 | 340,000 | — | $0 | 4,113,802 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-03-13 | 2025-03-17 | 51,425 | $15.07 | $775.0K | 4,062,377 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-03-04 | 2025-03-05 | 133,333 | $17.02 | $2.27M | 3,773,802 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2025-03-04 | 2025-03-05 | 133,333 | $7.75 | $1.03M | 4,073,802 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2025-03-03 | 2025-03-05 | 166,667 | — | $0 | 185,059 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2025-03-03 | 2025-03-05 | 133,333 | — | $0 | 51,726 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 166,667 | $18.03 | $3.01M | 3,907,135 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2025-03-03 | 2025-03-05 | 166,667 | $7.75 | $1.29M | 3,940,469 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-02-07 | 2025-02-10 | 9,550 | $20.10 | $192.0K | 3,773,802 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-02 | 2025-01-06 | 11,520 | $19.05 | $219.5K | 3,764,252 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-23 | 2024-12-23 | 12,563 | $19.59 | $246.1K | 3,775,772 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-12-18 | 2024-12-20 | 100,000 | — | $0 | 3,788,335 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-18 | 2024-12-20 | 5,799 | $22.12 | $128.3K | 3,688,335 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-18 | 2024-12-20 | 8,260 | $21.74 | $179.6K | 3,694,134 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-18 | 2024-12-20 | 12,653 | $20.52 | $259.6K | 3,702,394 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2024-01-31 | 2024-02-02 | 57,499 | — | $0 | 351,726 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-31 | 2024-02-02 | 37,769 | $32.16 | $1.21M | 3,734,778 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-31 | 2024-02-02 | 19,730 | $32.71 | $645.4K | 3,715,048 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2024-01-31 | 2024-02-02 | 57,499 | $14.54 | $836.0K | 3,772,547 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-02 | 2024-01-04 | 5,318 | $31.25 | $166.2K | 3,715,048 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-02 | 2024-01-04 | 4,634 | $30.74 | $142.4K | 3,720,366 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-12-20 | 2023-12-22 | 12,000 | $28.54 | $342.5K | 3,725,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-10-25 | 2023-10-27 | 24,338 | $24.21 | $589.2K | 3,737,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2023-09-18 | 2023-09-20 | 57,555 | — | $0 | 409,225 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-09-18 | 2023-09-20 | 26,232 | $28.27 | $741.6K | 3,761,338 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2023-09-18 | 2023-09-20 | 57,755 | $4.75 | $274.3K | 3,819,093 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-09-18 | 2023-09-20 | 31,523 | $28.00 | $882.6K | 3,787,570 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2023-05-04 | 2023-05-05 | 50,000 | — | $0 | 466,980 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2023-05-04 | 2023-05-05 | 50,000 | $2.01 | $100.5K | 3,811,338 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-05-04 | 2023-05-05 | 25,992 | $40.02 | $1.04M | 3,761,338 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-05-04 | 2023-05-05 | 24,008 | $38.97 | $935.6K | 3,787,330 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2023-05-03 | 2023-05-05 | 54,928 | — | $0 | 516,980 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2023-05-03 | 2023-05-05 | 54,928 | $2.01 | $110.4K | 3,816,266 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-05-03 | 2023-05-05 | 54,928 | $39.14 | $2.15M | 3,761,338 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-12-20 | 2022-12-20 | 234,025 | — | $0 | 3,720,714 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-12-16 | 2022-12-20 | 18,375 | — | $0 | 3,486,689 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2022-09-27 | 2022-09-29 | 1,542 | $31.21 | $48.1K | 3,468,314 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2022-09-27 | 2022-09-29 | 39,082 | $30.77 | $1.20M | 3,469,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | D To issuer | 2022-07-08 | 2022-07-12 | 551,197 | — | $0 | 3,508,938 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2022-07-07 | 2022-07-11 | 2,501 | — | $0 | 612,532 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2022-07-07 | 2022-07-11 | 2,501 | $14.54 | $36.4K | 4,060,135 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2022-02-11 | 2022-02-14 | 146,388 | — | $0 | 615,033 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2022-02-11 | 2022-02-14 | 146,388 | $5.19 | $759.8K | 4,204,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-02-11 | 2022-02-14 | 40,853 | $53.11 | $2.17M | 4,163,169 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-02-11 | 2022-02-14 | 42,153 | $52.28 | $2.20M | 4,121,016 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-02-11 | 2022-02-14 | 61,482 | $50.90 | $3.13M | 4,059,534 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-02-11 | 2022-02-14 | 1,900 | $50.51 | $96.0K | 4,057,634 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2022-01-07 | 2022-01-07 | 11,806 | — | $0 | 761,421 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2022-01-07 | 2022-01-07 | 11,806 | $5.19 | $61.3K | 4,057,634 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-01-01 | 2022-01-04 | 800,000 | — | $0 | 4,045,828 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2021-12-23 | 2021-12-23 | 11,806 | — | $0 | 773,227 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2021-12-23 | 2021-12-23 | 11,806 | $5.19 | $61.3K | 3,245,828 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-12-15 | 2021-12-17 | 25,857 | $66.28 | $1.71M | 3,253,165 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-12-15 | 2021-12-17 | 14,857 | $67.19 | $998.2K | 3,238,308 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-12-15 | 2021-12-17 | 9,223 | $69.52 | $641.2K | 3,226,011 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-12-15 | 2021-12-17 | 3,074 | $68.20 | $209.6K | 3,235,234 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-12-15 | 2021-12-17 | 6,989 | $70.19 | $490.6K | 3,219,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-10-22 | 2021-10-22 | 5,830 | $66.09 | $385.3K | 3,279,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-10-22 | 2021-10-22 | 44,170 | $65.57 | $2.90M | 3,284,852 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-10-20 | 2021-10-22 | 15,000 | $66.23 | $993.5K | 3,329,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2021-01-01 | 2021-01-04 | 800,000 | — | $0 | 3,344,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | G Gift | 2020-12-30 | 2021-01-04 | 599 | — | $0 | 2,544,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | G Gift | 2020-12-28 | 2020-12-30 | 1,126 | — | $0 | 2,544,621 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-12-18 | 2020-12-22 | 28,274 | — | $0 | 800,033 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-12-18 | 2020-12-22 | 12,236 | — | $0 | 828,307 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-12-18 | 2020-12-22 | 12,236 | $4.75 | $58.1K | 2,517,473 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-12-18 | 2020-12-22 | 28,274 | $6.15 | $173.9K | 2,545,747 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-12-09 | 2020-12-10 | 38,676 | — | $0 | 840,543 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-12-09 | 2020-12-10 | 4,003 | $71.61 | $286.7K | 2,505,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-12-09 | 2020-12-10 | 5,880 | $70.87 | $416.7K | 2,509,240 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-12-09 | 2020-12-10 | 12,067 | $69.80 | $842.3K | 2,515,120 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-12-09 | 2020-12-10 | 16,726 | $67.27 | $1.13M | 2,527,187 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-12-09 | 2020-12-10 | 38,676 | $2.01 | $77.7K | 2,543,913 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-12-08 | 2020-12-10 | 16,324 | — | $0 | 879,219 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-12-08 | 2020-12-10 | 16,324 | $2.01 | $32.8K | 2,521,561 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-12-08 | 2020-12-10 | 16,324 | $67.97 | $1.11M | 2,505,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-10-23 | 2020-10-23 | 12,272 | $58.57 | $718.8K | 2,505,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-10-23 | 2020-10-23 | 87,728 | $58.16 | $5.10M | 2,517,509 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-08-13 | 2020-08-14 | 50,000 | — | $0 | 895,543 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-08-13 | 2020-08-14 | 50,000 | $9.90 | $495.0K | 2,655,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-08-13 | 2020-08-14 | 50,000 | $41.35 | $2.07M | 2,605,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-06-25 | 2020-06-26 | 23 | $39.55 | $910 | 2,605,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-06-25 | 2020-06-26 | 99,977 | $38.81 | $3.88M | 2,605,260 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2020-01-01 | 2020-01-03 | 900,000 | — | $0 | 2,705,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-24 | 2019-12-27 | 83,333 | $63.50 | $5.29M | 1,805,237 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-13 | 2019-12-13 | 3,393 | $68.18 | $231.3K | 1,888,570 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-13 | 2019-12-13 | 25,412 | $67.30 | $1.71M | 1,891,963 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-13 | 2019-12-13 | 45,577 | $66.47 | $3.03M | 1,917,375 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-13 | 2019-12-13 | 8,951 | $65.85 | $589.4K | 1,962,952 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-12 | 2019-12-13 | 10,343 | $68.51 | $708.6K | 1,980,282 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-12 | 2019-12-13 | 23,219 | $66.82 | $1.55M | 2,048,684 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-12 | 2019-12-13 | 58,059 | $67.31 | $3.91M | 1,990,625 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-12 | 2019-12-13 | 8,379 | $69.41 | $581.6K | 1,971,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-03 | 2019-12-04 | 4,011 | $60.73 | $243.6K | 2,079,925 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-03 | 2019-12-04 | 8,022 | $62.00 | $497.4K | 2,071,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 2,448 | $70.72 | $173.1K | 2,091,392 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 3,656 | $72.95 | $266.7K | 2,083,936 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 3,800 | $72.13 | $274.1K | 2,087,592 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 6,617 | $69.50 | $459.9K | 2,093,840 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 8,510 | $68.50 | $582.9K | 2,100,457 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 7,193 | $67.63 | $486.5K | 2,108,967 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-12-02 | 2019-12-04 | 5,743 | $66.58 | $382.4K | 2,116,160 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-10-10 | 2019-10-11 | 56,325 | — | $0 | 945,543 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-10-10 | 2019-10-11 | 56,325 | $5.20 | $292.9K | 2,178,228 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-10-10 | 2019-10-11 | 56,325 | $31.83 | $1.79M | 2,121,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-25 | 2019-09-27 | 20,000 | $28.25 | $565.0K | 2,121,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-09-24 | 2019-09-24 | 66,645 | — | $0 | 1,001,868 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-09-24 | 2019-09-24 | 66,645 | $5.10 | $339.9K | 2,208,548 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-24 | 2019-09-24 | 12,673 | $29.04 | $368.0K | 2,141,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-24 | 2019-09-24 | 53,972 | $28.00 | $1.51M | 2,154,576 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-09-23 | 2019-09-24 | 41,755 | — | $0 | 1,068,513 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-23 | 2019-09-24 | 41,755 | $29.04 | $1.21M | 2,141,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-09-23 | 2019-09-24 | 41,755 | $5.10 | $213.0K | 2,183,658 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-09-20 | 2019-09-24 | 4,250 | — | $0 | 1,110,268 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-09-20 | 2019-09-24 | 4,250 | $5.10 | $21.7K | 2,146,153 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-20 | 2019-09-24 | 4,250 | $29.00 | $123.3K | 2,141,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-05-24 | 2019-05-29 | 9,376 | — | $0 | 1,133,418 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-05-24 | 2019-05-29 | 40,072 | — | $0 | 1,142,794 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-05-24 | 2019-05-29 | 9,376 | $2.62 | $24.6K | 2,141,903 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-05-24 | 2019-05-29 | 40,072 | $2.01 | $80.5K | 2,132,527 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-04-03 | 2019-04-05 | 50,000 | $19.30 | $965.0K | 2,092,455 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2019-01-01 | 2019-01-03 | 600,000 | — | $0 | 2,142,455 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-12-19 | 2018-12-21 | 90,000 | $13.92 | $1.25M | 1,542,455 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-12-12 | 2018-12-14 | 90,000 | $14.07 | $1.27M | 1,632,455 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-11-09 | 2018-11-09 | 76,200 | $14.35 | $1.09M | 1,727,755 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-11-09 | 2018-11-09 | 5,300 | $14.95 | $79.2K | 1,722,455 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-09-04 | 2018-09-05 | 64,834 | $14.45 | $936.9K | 1,803,955 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-08-31 | 2018-09-05 | 100,000 | $14.45 | $1.45M | 1,868,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-16 | 2018-03-16 | 26,000 | $7.40 | $192.4K | 1,968,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-15 | 2018-03-15 | 100,000 | $7.41 | $741.0K | 1,994,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-14 | 2018-03-15 | 100,000 | $7.44 | $744.0K | 2,094,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-13 | 2018-03-15 | 100,000 | $7.43 | $743.0K | 2,194,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2018-01-01 | 2018-01-03 | 500,000 | — | $0 | 2,294,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2017-04-12 | 2017-04-14 | 978,000 | — | $0 | 1,794,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | F Tax w/h | 2016-12-13 | 2016-12-15 | 300,444 | $1.27 | $381.6K | 816,789 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | X Exercise deriv | 2016-06-30 | 2016-07-05 | 15,772 | — | $0 | 0 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2016-06-30 | 2016-07-05 | 15,772 | $5.09 | $80.3K | 1,117,233 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2016-01-01 | 2016-01-04 | 80,000 | — | $0 | 1,166,466 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2016-01-01 | 2016-01-04 | 540,000 | — | $0 | 1,101,461 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2015-12-30 | 2016-01-04 | 58,712 | $6.13 | $359.9K | 561,461 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2015-03-06 | 2015-03-06 | 300,000 | — | $0 | 1,086,466 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2015-03-04 | 2015-03-06 | 360,000 | — | $0 | 620,173 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | P Buy | 2014-10-15 | 2014-10-15 | 16,000 | $6.32 | $101.1K | 260,173 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | P Buy | 2014-10-15 | 2014-10-15 | 16,000 | $6.32 | $101.1K | 260,173 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2014-02-06 | 2014-02-10 | 60,000 | — | $0 | 786,466 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2014-02-06 | 2014-02-10 | 210,000 | — | $0 | 244,173 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-09-21 | 2013-09-24 | 69,991 | — | $0 | 726,466 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-05-06 | 2013-05-08 | 200,000 | — | $0 | 656,475 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-09-28 | 2012-10-02 | 50,000 | — | $0 | 456,475 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-02-16 | 2012-02-21 | 170,000 | — | $0 | 406,475 | SEC↗ |